New debate of revascularization strategy of non-infarct-related artery lesions in patients with ST-segment elevation myocardial infarction and cardiogenic shock:decoding the CULPRIT-SHOCK trial,not enough to challenge the current guidelines

To the Editor: Research result of CULPRIT-SHOCK trial[1] presented at the Transcatheter Cardiovascular Therapeutics (TCT) 2017 conference suggested that acute myocardial infarction (AMI) patients with multivessel disease (MVD) and cardiogenic shock undergoing primary percutaneous coronary interventions (PCI) treated with culprit-only revascularization (COR) strategy had lower mortality at one month compared with immediate complete revascularization in single procedure (CRS) strategy, which challenge current guidelines and years of consensus[2-5].